Hotbed/Location
Filter News
Found 489,381 articles
-
Hansa Medical AB to Present at the Evercore ISI HealthConX Conference
11/21/2018
Søren Tulstrup, President and CEO of Hansa Medical, will present at the Evercore ISI HealthConX Conference at the Boston Harbor Hotel on Tuesday, November 27, 2018 at 10:35 am ET.
-
Ocular Therapeutix™ to Present at the 30th Annual Piper Jaffray Healthcare Conference
11/21/2018
Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018 at 3:00 PM ET at the Lotte New York Palace Hotel in New York, NY.
-
Fourth Annual National Compensation Guide for Canada’s Bio-Economy Launched by BioTalent Canada
11/21/2018
BioTalent Canada announced the release of its fourth annual National Compensation Guide for Canada’s bio-economy today.
-
Nevada 2-1-1 Recognized with the CARE Coalition Resource Award
11/21/2018
Over 270,000 Nevadans have been assisted by the 2-1-1 hotline since 2015
-
Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
11/21/2018
Single Phase 3 Clinical Trial May be Sufficient for Approval for Prevention of Antibiotic-Mediated Clostridium difficile Infection (CDI)
-
Portage announces setting of meeting date to approve SalvaRx acquisition
11/21/2018
The meeting is scheduled for January 8th, 2019 for shareholders of record as of November 23, 2018.
-
Convention-Busting Experience Life Magazine Expands National and Local Acclaim
11/21/2018
On the heels of receiving four awards at FOLIO: in October, Experience Life, the whole-life health and fitness magazine, was awarded top honors in six categories on Thursday, November 1, at the Minnesota Media and Publishing Association (MMPA) Excellence Awards
-
Kleresca® Employs Industrial Postdoc Researcher to Investigate Impact of Fluorescent Light Energy (FLE) on Human Immune System
11/21/2018
Kleresca® has strengthened its research activities by employing an industrial postdoc to investigate the impact of FLE on skin macrophages.
-
Getinge Capital Markets Day
11/21/2018
Today at Getinge's Capital Markets Day the President & CEO Mattias Perjos, together with the Getinge Executive Team, will present the strategy and related Business Area plans needed to improve company performance.
-
FDA Closes Inquiry Regarding IHCTOA Letter Regarding Sciton's diVa® Laser
11/21/2018
Sciton, Inc. announced today that the FDA has advised the company that it appears that Sciton has satisfactorily addressed all items raised by the FDA in its July 24, 2018 "It Has Come to Our Attention" letter.
-
After announcing a potential snag with the European Commission last month, Takeda said this morning that it received clearance for its acquisition of Shire. The clearance is conditional on addressing overlaps in the companies’ inflammatory bowel disease businesses.
-
The Biotechnology Industry Organization (BIO) published the fifth edition of the Building the Bioeconomy report recently. The report studied 28 different indicators and provided analysis and insight into the biotech environment for 33 countries. The goal of the report is to determine how successf...
-
Interview: Survey Numbers Show California’s Life Science Industry Is an Economic Powerhouse
11/20/2018
The number of life science jobs grew by 12,500 for an approximate total of a total estimated employment of 311,226. That was music to the ears of Sara Radcliffe, president and chief executive officer of the California Life Sciences Association. -
Under the terms of the deal, Roivant is paying iNtRON Bio $10 million upfront. iNtRON will be eligible for milestone payments. When the first patient receives treatment in a U.S. Phase II clinical trial scheduled for 2019, the first milestone will be $30 million.
-
Seven African American seek unspecified damages over allegations of discrimination at Charleston, S.C. facility.
-
Merck KGaA, Darmstadt, Germany Enters Field of Big Data With Joint Venture With Palantir Technolo...
11/20/2018
Germany’s pharma giant Merck KGaA, Darmstadt, Germany and Silicon Valley data analytics company Palantir Technologies are forming a joint venture called Syntropy. Syntropy will be based in Boston and will focus on cancer data analytics tools. -
Seqirus, a wholly owned subsidiary of CSL, is expanding its manufacturing plant in North Carolina. It expects to invest $140 million in the expansion.
-
Less than a week after Boston Scientific announced that it was undergoing a restructuring that could result in some job losses, the company announced that it will acquire U.K.-based BTG plc., a surgical device manufacturer for about $4.2 billion.
-
PellePharm’s Phase III Skin Disease Trial Is Back on Track Following Agreement With LEO Pharma
11/20/2018
Denmark-based LEO Pharma and California rare disease drugmaker PellePharm entered into a strategic collaboration worth $760 million to address unmet needs in multiple orphan skin diseases, such as Gorlin Syndrome and High-Frequency Basal Cell Carcinomas (BCCs), two rare forms of skin cancer. -
Two Research Studies Supported by Medidata to be Presented at ASH 2018
11/20/2018
Medidata Rave Omics Machine Learning Identifies New Evidence of Biomarkers in Rare Disease Research by the Castleman Disease Collaborative Network